Lupus Nephritis Global Clinical Trials Review, H1, 2013

• Publication date: February 2013
• Report size: 108 pages

Lupus Nephritis Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Lupus Nephritis Global Clinical Trials Review, H1, 2013" provides data on the Lupus Nephritis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Lupus Nephritis. It includes an overview of the trial numbers and their recruitment status as per the si...

Lupus Nephritis Global Clinical Trials Review, H1, 2013



Summary



GlobalData's clinical trial report, “Lupus Nephritis Global Clinical Trials Review, H1, 2013" provides data on the Lupus Nephritis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Lupus Nephritis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Lupus Nephritis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.



Scope


- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)



Reasons to buy


- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Global Drug Discovery And Development Industry

Table of Contents
Table of Contents 2
List of Tables 6
List of Figures 8
Introduction 10
Lupus Nephritis 10
Report Guidance 10
Clinical Trials by Region 11
Clinical Trials by Country 12
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 14
Top Five Countries Contributing to Clinical Trials in Europe 15
Top Countries Contributing to Clinical Trials in North America 16
Top Countries Contributing to Clinical Trials in Middle East and Africa 17
Top Five Countries Contributing to Clinical Trials in Central and South America 18
Clinical Trials by BRIC Nations 19
Clinical Trials by G7 Nations 20
Clinical Trials in G7 Nations by Trial Status 21
Clinical Trials by E7 Nations 22
Clinical Trials in E7 Nations by Trial Status 23
Clinical Trials by Phase 24
In Progress Trials by Phase 25
Clinical Trials by Trial Status 26
Unaccomplished Trials of Lupus Nephritis 27
Subjects Recruited Over a Period of Time 30
Prominent Sponsors 31
Top Companies Participating in Lupus Nephritis Therapeutics Clinical Trials 33
Prominent Drug Comparison 35
Clinical Trial Profiles 36
Clinical Trial Overview of Top Companies 36
Astellas Pharma Inc. 36
Clinical Trial Overview of Astellas Pharma Inc. 36
Novartis AG 37
Clinical Trial Overview of Novartis AG 37
Genentech, Inc. 38
Clinical Trial Overview of Genentech, Inc. 38
Merck KGaA 39
Clinical Trial Overview of Merck KGaA 39
Anthera Pharmaceuticals‚ Inc. 40
Clinical Trial Overview of Anthera Pharmaceuticals‚ Inc. 40
La Jolla Pharmaceutical Company 41
Clinical Trial Overview of La Jolla Pharmaceutical Company 41
F. Hoffmann-La Roche Ltd. 42
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 42
Janssen Research & Development, LLC 43
Clinical Trial Overview of Janssen Research & Development, LLC 43
Bristol-Myers Squibb Company 44
Clinical Trial Overview of Bristol-Myers Squibb Company 44
Cytomed 45
Clinical Trial Overview of Cytomed 45
SuppreMol GmbH 46
Clinical Trial Overview of SuppreMol GmbH 46
Baxter International Inc. 47
Clinical Trial Overview of Baxter International Inc. 47
Teva Pharmaceutical Industries Limited 48
Clinical Trial Overview of Teva Pharmaceutical Industries Limited 48
Nippon Kayaku Co., Ltd. 49
Clinical Trial Overview of Nippon Kayaku Co., Ltd. 49
Human Genome Sciences, Inc. 50
Clinical Trial Overview of Human Genome Sciences, Inc. 50
Biogen Idec Inc. 51
Clinical Trial Overview of Biogen Idec Inc. 51
Clinical Trial Overview of Top Universities / Institutes / Hospitals 52
Nanjing University 52
Clinical Trial Overview of Nanjing University 52
Chinese University of Hong Kong 53
Clinical Trial Overview of Chinese University of Hong Kong 53
Sun Yat-sen University 54
Clinical Trial Overview of Sun Yat-sen University 54
Faculty of Pharmaceutical Sciences, Chulalongkorn University 55
Clinical Trial Overview of Faculty of Pharmaceutical Sciences, Chulalongkorn University 55
Zhejiang University 56
Clinical Trial Overview of Zhejiang University 56
Tuen Mun Hospital 57
Clinical Trial Overview of Tuen Mun Hospital 57
University of Calgary 58
Clinical Trial Overview of University of Calgary 58
University Medical Center Groningen 59
Clinical Trial Overview of University Medical Center Groningen 59
Saitama Medical University 60
Clinical Trial Overview of Saitama Medical University 60
Ramathibodi Hospital 61
Clinical Trial Overview of Ramathibodi Hospital 61
Universite Catholique de Louvain 62
Clinical Trial Overview of Universite Catholique de Louvain 62
Peking University 63
Clinical Trial Overview of Peking University 63
The Rogosin Institute 64
Clinical Trial Overview of The Rogosin Institute 64
Katholieke Universiteit Leuven 65
Clinical Trial Overview of Katholieke Universiteit Leuven 65
Medical University of Vienna 66
Clinical Trial Overview of Medical University of Vienna 66
The University of Hong Kong 67
Clinical Trial Overview of The University of Hong Kong 67
Shanghai Jiao Tong University 68
Clinical Trial Overview of Shanghai Jiao Tong University 68
Hospital Authority 69
Clinical Trial Overview of Hospital Authority 69
Assistance Publique Hopitaux De Marseille 70
Clinical Trial Overview of Assistance Publique Hopitaux De Marseille 70
Seoul National University Hospital 71
Clinical Trial Overview of Seoul National University Hospital 71
Five Key Clinical Profiles 72
Appendix 105
Abbreviations 105
Definitions 105
Research Methodology 106
Secondary Research 106
About GlobalData 107
Contact Us 107
Disclaimer 107
Source 108



List of Tables
Lupus Nephritis Therapeutics Market, Global, Clinical Trials by Zone, 2013* 11
Lupus Nephritis Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 12
Lupus Nephritis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 13
Lupus Nephritis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 14
Lupus Nephritis Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 15
Lupus Nephritis Therapeutics Clinical Trials, North America, Top Countries, 2013* 16
Lupus Nephritis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013* 17
Lupus Nephritis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013* 18
Lupus Nephritis Therapeutics Clinical Trials, BRIC Countries, 2013* 19
Lupus Nephritis Therapeutics Clinical Trials, G7 Countries, 2013* 20
Lupus Nephritis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 21
Lupus Nephritis Therapeutics Clinical Trials, E7 Countries, 2013* 22
Lupus Nephritis Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 23
Lupus Nephritis Therapeutics Market, Global, Clinical Trials by Phase, 2013* 24
Lupus Nephritis Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 25
Lupus Nephritis Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 26
Lupus Nephritis Therapeutics Market, Global, Suspended Clinical Trials, 2013* 27
Lupus Nephritis Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 28
Lupus Nephritis Therapeutics Market, Global, Terminated Clinical Trials, 2013* 29
Lupus Nephritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 30
Lupus Nephritis Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 32
Lupus Nephritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 34
Lupus Nephritis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 35
Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2013* 36
Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2013* 37
Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Genentech, Inc., 2013* 38
Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck KGaA, 2013* 39
Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Anthera Pharmaceuticals‚ Inc., 2013* 40
Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by La Jolla Pharmaceutical Company, 2013* 41
Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2013* 42
Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Research & Development, LLC, 2013* 43
Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2013* 44
Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Cytomed, 2013* 45
Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by SuppreMol GmbH, 2013* 46
Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter International Inc., 2013* 47
Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceutical Industries Limited, 2013* 48
Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Nippon Kayaku Co., Ltd., 2013* 49
Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Human Genome Sciences, Inc., 2013* 50
Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Biogen Idec Inc., 2013* 51
Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Nanjing University, 2013* 52
Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2013* 53
Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2013* 54
Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Faculty of Pharmaceutical Sciences, Chulalongkorn University, 2013* 55
Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Zhejiang University, 2013* 56
Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Tuen Mun Hospital, 2013* 57
Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Calgary, 2013* 58
Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Medical Center Groningen, 2013* 59
Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Saitama Medical University, 2013* 60
Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ramathibodi Hospital, 2013* 61
Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Universite Catholique de Louvain, 2013* 62
Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Peking University, 2013* 63
Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by The Rogosin Institute, 2013* 64
Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Katholieke Universiteit Leuven, 2013* 65
Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2013* 66
Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Hong Kong, 2013* 67
Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Shanghai Jiao Tong University, 2013* 68
Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Authority, 2013* 69
Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique Hopitaux De Marseille, 2013* 70
Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2013* 71



List of Figures
Lupus Nephritis Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 11
Lupus Nephritis Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 12
Lupus Nephritis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 13
Lupus Nephritis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 14
Lupus Nephritis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 15
Lupus Nephritis Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 16
Lupus Nephritis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2013* 17
Lupus Nephritis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013* 18
Lupus Nephritis Therapeutics Clinical Trials, BRIC Countries (%), 2013* 19
Lupus Nephritis Therapeutics Clinical Trials, G7 Countries (%), 2013* 20
Lupus Nephritis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 21
Lupus Nephritis Therapeutics Clinical Trials, E7 Countries (%), 2013* 22
Lupus Nephritis Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 23
Lupus Nephritis Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 24
Lupus Nephritis Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 25
Lupus Nephritis Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 26
Lupus Nephritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 30
Lupus Nephritis Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 31
Lupus Nephritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 33
Lupus Nephritis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 35
GlobalData Methodology 106